Share this @internewscast.com

The U.S. Food and Drug Administration on Thursday said it was banning the sale of Reynolds American Vuse Alto menthol e-cigarettes, saying the risk to kids outweighs any benefit to adult smokers. 

The FDA said its ban includes three menthol-flavored and three mixed berry-flavored products, each offered in three different nicotine strengths. The agency is continuing to weigh whether to let the company’s tobacco flavors stay on the market. 

Reynolds, the maker of Camel and Newport cigarettes, has made the case that the vape pens help adults kick the smoking habit by switching to products less damaging to their health.  

Reynolds’ parent company, British American Tobacco, or BAT, said it would challenge the FDA’s decision in court.

“We believe appropriately regulated flavored vaping products — including menthol — are critical in supporting adult smokers migrate from combustible cigarettes,” Kingsley Wheaton, BAT’s chief strategy and growth officer, said in a news release. 

On the market for multiple years, the vape pens have become increasingly popular among children and teenagers. Nearly 13% of middle- and high-school students who have vaped in the past 30 days named Vuse as their preferred brand, coming in second after Puff Bar, according to the results of a federal survey published in 2022. 


New Netflix docuseries “Big Vape” looks at the rise and fall of Juul

06:06

The FDA last year ordered Juul Labs to stop selling its vaping products, but the ban was put on hold while Juul appealed, with that challenge ongoing. 

Share this @internewscast.com
You May Also Like

Scientists Uncover Surprising Effects on Stress, Sleep, and Memory After a Two-Week Coffee Break

Cutting out coffee for just a fortnight could lead to reduced impulsivity…

Discover the Affordable Supplement Enhancing Ozempic’s Effects and Lowering Cholesterol: Experts Explain Why It’s Essential for Weight Maintenance

In recent times, a significant number of individuals have turned to medications…

NHS App Outage Leaves Patients Struggling to Access Healthcare Services

In an unexpected turn of events, a significant technical glitch left millions…

Many in the UK Skip Doctor Visits Due to Embarrassment and Anxiety Over Diagnosis

More than a third haven’t been see their GP in the past…